MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Operating Expenses 2011-2025 | BRKR
Annual Operating Expenses Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.4 B | 1.08 B | 873 M | 796 M | 678 M | 696 M | 631 M | 583 M | 546 M | 557 M | 646 M | 634 M | 649 M | 584 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.4 B | 546 M | 739 M |
Quarterly Operating Expenses Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 431 M | 359 M | - | 351 M | 336 M | 288 M | - | 258 M | 254 M | 237 M | - | 204 M | 224 M | 210 M | - | 196 M | 195 M | 190 M | - | 167 M | 148 M | 176 M | - | 166 M | 177 M | 173 M | - | 154 M | 156 M | 161 M | - | 148 M | 149 M | 139 M | - | 139 M | 150 M | 133 M | - | 139 M | 138 M | 145 M | - | 162 M | 165 M | 159 M | - | 162 M | 158 M | 162 M | - | 150 M | 166 M | 156 M | - | 152 M | 145 M | 136 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 431 M | 133 M | 190 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
456 M | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.78 | -2.01 % | $ 131 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 306.14 | -0.65 % | $ 8.64 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 14.33 | -1.24 % | $ 1.14 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 0.98 | 5.89 % | $ 15.8 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 128.15 | 2.14 % | $ 223 B | USA |
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 91.93 | -0.7 % | $ 135 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 63.0 | 0.4 % | $ 3.42 B |  Britain |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.27 | 13.54 % | $ 122 M |  France |
 |
LENSAR
LNSR
|
32.6 M | $ 11.73 | 1.91 % | $ 135 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
PAVmed
PAVM
|
54.3 M | $ 0.31 | -4.73 % | $ 2.24 M | USA |
|
Cognyte Software Ltd.
CGNT
|
293 M | $ 9.6 | -2.64 % | $ 689 M | Israel |
 |
Profound Medical Corp.
PROF
|
33 M | $ 7.75 | 5.73 % | $ 180 M | Canada |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 96.49 | 0.26 % | $ 1.22 B | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
120 M | $ 7.48 | -1.06 % | $ 281 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 163.48 | -1.18 % | $ 12.2 B | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 1.05 | -0.94 % | $ 108 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 12.59 | -0.94 % | $ 340 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 14.9 | 1.02 % | $ 97.7 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 29.87 | -1.71 % | $ 1.32 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 40.13 | -1.71 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
184 M | $ 17.69 | 0.51 % | $ 408 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 86.39 | -0.36 % | $ 11.7 B | USA |
 |
Sensus Healthcare
SRTS
|
16.3 M | $ 3.69 | -3.79 % | $ 60.2 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 13.55 | 0.93 % | $ 1.04 B | USA |